Compliance Management Featured Articles

  1. Managing Compliance Risks With Cloud-Native EAM/CMMS 3/23/2026

    What separates systems that maintain compliance effortlessly from those that struggle? Test mobile offline signatures, automated OOT workflows, and integration traceability during vendor evaluations.

  2. FDA's CSA Guidance Is Final: What It Means For Your Validation Strategy 3/23/2026

    Understand the FDA's shift from rigid CSV to risk-based software assurance. Binary risk classification and flexible testing approaches reduce validation timelines for production and quality.

  3. Choosing 21 CFR Part 11 Software: A Practical Buyer's Guide 3/23/2026

    Electronic records require audit trails, two-component signatures, authority checks, and ALCOA+ controls. See how to evaluate Part 11 software, build validation packages, and maintain inspection readiness.

  4. The Complete Guide To Computer System Validation 3/23/2026

    Understand the three-phase validation protocol that proves computer systems meet FDA requirements for accuracy, security, and reliability under 21 CFR Part 11 compliance standards.

  5. Unifying EAM And ERP: Transform Asset Management In Life Sciences 3/23/2026

    Fragmented systems create compliance risks and operational inefficiencies. Learn how integrated asset management and ERP platforms eliminate duplicate work while maintaining audit-ready documentation.

  6. One Less Risk: Why ISO 27001 Certification Matters For Your FDA Audits 3/23/2026

    ISO 27001 certification offers independently verified security controls that reduce qualification burden. Learn how this framework supports Part 11 compliance, GAMP 5 validation, and audit readiness.

  7. Purpose Built Calibration Management In Life Sciences 3/23/2026

    Discover how purpose-built calibration platforms automate compliance through native OOT workflows and NIST traceability, while generic ERP systems require extensive customization.

  8. Generative AI Can Write The Code, But Who Builds In The Quality? 3/23/2026

    Code democratization demands a return to the fundamentals of quality in pharmaceutical and regulated environments.

  9. Quantifying Endotoxins Via Absorbance Or Fluorescence 3/20/2026

    Find out how endotoxin assays use Factor C activation to generate measurable absorbance or fluorescence signals, with guidance on selecting detection formats and implementing scalable workflows.

  10. A Risk-Based Decision Framework For Selecting Aseptic Barrier Technologies 3/20/2026

    EU GMP Annex 1 requires a risk-based approach to selecting Isolators or RABS. This framework evaluates human intervention and decontamination to ensure robust sterility assurance.